190 related articles for article (PubMed ID: 35240798)
1. Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors.
Gomez J; Holmes N; Hansen A; Adhikarla V; Gutova M; Rockne RC; Cho H
Math Biosci Eng; 2022 Jan; 19(3):2592-2615. PubMed ID: 35240798
[TBL] [Abstract][Full Text] [Related]
2. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
[TBL] [Abstract][Full Text] [Related]
3. Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.
Barish ME; Herrmann K; Tang Y; Argalian Herculian S; Metz M; Aramburo S; Tirughana R; Gutova M; Annala A; Moats RA; Goldstein L; Rockne RC; Gutierrez J; Brown CE; Ghoda L; Aboody KS
Stem Cells Transl Med; 2017 Jun; 6(6):1522-1532. PubMed ID: 28481046
[TBL] [Abstract][Full Text] [Related]
4. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2020 Oct; ():. PubMed ID: 33085922
[TBL] [Abstract][Full Text] [Related]
5. Long-term stability and computational analysis of migration patterns of L-MYC immortalized neural stem cells in the brain.
Rockne RC; Adhikarla V; Tsaturyan L; Li Z; Masihi MB; Aboody KS; Barish ME; Gutova M
PLoS One; 2018; 13(8):e0199967. PubMed ID: 30071048
[TBL] [Abstract][Full Text] [Related]
6. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.
Lin D; Najbauer J; Salvaterra PM; Mamelak AN; Barish ME; Garcia E; Metz MZ; Kendall SE; Bowers M; Kateb B; Kim SU; Johnson M; Aboody KS
Neuroimage; 2007; 37 Suppl 1():S18-26. PubMed ID: 17560798
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract][Full Text] [Related]
8. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
9. Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.
Kim JH; Lee JE; Kim SU; Cho KG
Neurosurgery; 2010 Feb; 66(2):333-42; discussion 342. PubMed ID: 20087133
[TBL] [Abstract][Full Text] [Related]
10. Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line.
Khosh N; Brown CE; Aboody KS; Barish ME
PLoS One; 2012; 7(12):e51859. PubMed ID: 23240066
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
[TBL] [Abstract][Full Text] [Related]
14. Migration of human neural stem cells toward an intracranial glioma.
Jeon JY; An JH; Kim SU; Park HG; Lee MA
Exp Mol Med; 2008 Feb; 40(1):84-91. PubMed ID: 18305401
[TBL] [Abstract][Full Text] [Related]
15. Neural stem cell tropism to glioma: critical role of tumor hypoxia.
Zhao D; Najbauer J; Garcia E; Metz MZ; Gutova M; Glackin CA; Kim SU; Aboody KS
Mol Cancer Res; 2008 Dec; 6(12):1819-29. PubMed ID: 19074827
[TBL] [Abstract][Full Text] [Related]
16. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
17. Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy.
Teng J; Hejazi S; Badr CE; Tannous BA
Stem Cells; 2014 Aug; 32(8):2021-32. PubMed ID: 24801379
[TBL] [Abstract][Full Text] [Related]
18. Neural Stem Cells Expressing bFGF Reduce Brain Damage and Restore Sensorimotor Function after Neonatal Hypoxia-Ischemia.
Ye Q; Wu Y; Wu J; Zou S; Al-Zaazaai AA; Zhang H; Shi H; Xie L; Liu Y; Xu K; He H; Zhang F; Ji Y; He Y; Xiao J
Cell Physiol Biochem; 2018; 45(1):108-118. PubMed ID: 29316558
[TBL] [Abstract][Full Text] [Related]
19. Gliomagenesis and the use of neural stem cells in brain tumor treatment.
Achanta P; Sedora Roman NI; QuiƱones-Hinojosa A
Anticancer Agents Med Chem; 2010 Feb; 10(2):121-30. PubMed ID: 20184546
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
Spencer D; Yu D; Morshed RA; Li G; Pituch KC; Gao DX; Bertolino N; Procissi D; Lesniak MS; Balyasnikova IV
Theranostics; 2019; 9(7):2071-2083. PubMed ID: 31037157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]